2024-02-06 20:24:07 ET
Gilead Sciences, Inc. (GILD)
Q4 2023 Earnings Call Transcript
February 06, 2024, 05:00 PM ET
Company Participants
Jacquie Ross - Vice President, Investor Relations
Daniel O’Day - Chairman and Chief Executive Officer
Johanna Mercier - Chief Commercial Officer
Merdad Parsey - Chief Medical Officer
Andrew Dickinson - Chief Financial Officer
Cindy Perettie - Executive Vice President, Kite
Conference Call Participants
Tyler Van Buren - TD Cowen
Salveen Richter - Goldman Sachs
Leon Wang - Barclays
Terrence Flynn - Morgan Stanley
Umer Raffat - Evercore
Olivia Brayer - Cantor Fitzgerald
Geoff Meacham - Bank of America
Michael Yee - Jefferies
Chris Schott - JPMorgan
Brian Abrahams - RBC Capital Markets
Presentation
Operator
Good afternoon. Thank you for attending the Four Quarter and Full Year 2023 Gilead Sciences Earning Conference Call. My name is Victoria, and I'll be your moderator today. All lines will be muted during the presentation portion of the call with the opportunity for questions and answers at the end.
I would now like to pass the conference over to your host, Jacquie Ross. Thank you. You may proceed, Jacquie.
Jacquie Ross
Thank you, Operator, and good afternoon, everyone. Just after market close today, we issued a press release with earnings results for the fourth quarter and full year of 2023. The press release, slides, and supplementary data are available on the Investors section of our website at gilead.com.
The speakers on today’s call will be our Chairman and Chief Executive Officer, Daniel O’Day; our Chief Commercial Officer, Johanna Mercier; our Chief Medical Officer, Merdad Parsey; and our Chief Financial Officer, Andrew Dickinson. After that, we’ll open the call to Q&A, where the team will be joined by Cindy Perettie, the Executive Vice President of Kite....
Read the full article on Seeking Alpha
For further details see:
Gilead Sciences, Inc. (GILD) Q4 2023 Earnings Call Transcript